Literature DB >> 26277195

The α- and β-Adrenergic Antagonist Controversy with Sympathomimetic Agents.

Matthew L Banks1, Travis J Worst2, Daniel E Rusyniak3, Jon E Sprague4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26277195      PMCID： PMC5786445          DOI： 10.1016/j.jemermed.2015.06.004

Source DB:  PubMed          Journal:  J Emerg Med        ISSN： 0736-4679            Impact factor:   1.484


× No keyword cloud information.
  6 in total

1.  Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans.

Authors:  Cm Hysek; Y Schmid; A Rickli; L D Simmler; M Donzelli; E Grouzmann; M E Liechti
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

Review 2.  Synthetic cathinones ("bath salts").

Authors:  Matthew L Banks; Travis J Worst; Daniel E Rusyniak; Jon E Sprague
Journal:  J Emerg Med       Date:  2014-02-22       Impact factor: 1.484

3.  Beta-blocker use for toxicity from "bath salts".

Authors:  John R Richards; Erik G Laurin; Timothy E Albertson
Journal:  J Emerg Med       Date:  2014-11-18       Impact factor: 1.484

Review 4.  2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Jeffrey L Anderson; Cynthia D Adams; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis M Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette K Wenger; R Scott Wright; Hani Jneid; Steven M Ettinger; Theodore G Ganiats; George J Philippides; Alice K Jacobs; Jonathan L Halperin; Nancy M Albert; Mark A Creager; David DeMets; Robert A Guyton; Frederick G Kushner; E Magnus Ohman; William Stevenson; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2013-04-29       Impact factor: 24.094

5.  Effects of a beta-blocker on the cardiovascular response to MDMA (Ecstasy).

Authors:  C M Hysek; F X Vollenweider; M E Liechti
Journal:  Emerg Med J       Date:  2010-04-08       Impact factor: 2.740

6.  Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) in an animal model.

Authors:  Jon E Sprague; Petra Moze; David Caden; Daniel E Rusyniak; Courtney Holmes; David S Goldstein; Edward M Mills
Journal:  Crit Care Med       Date:  2005-06       Impact factor: 7.598
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.